As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: July 21, 2016
by David Oliver for U.S. News & World Report:
Alzheimer’s disease, the debilitating neurological disorder, is evidently more than meets the eye.
Researchers at the University of Minnesota used technology to discover early signs of the condition in the retinas of mice, and they’re hopeful the same could be found in humans.
The University of Minnesota Center for Drug Design study was published in June in the journal Investigative Ophthalmology and Visual Science.
The simple, noninvasive test involves examining retinas, the light-sensitive tissue that coats the back of eyes, through a camera. The retina and brain undergo similar changes due to Alzheimer’s, but the retina is much easier to see since it’s more accessible.
Indeed, researchers detected patterns in the retinas – through changes in light reflection as early stages of amyloid plaque gathered – that signified the disease’s progression. Amyloid plaque is a key marker for Alzheimer’s disease. Alzheimer’s disease can currently only be identified after it’s already formed, Dr. Robert Vince, director of the Center for Drug Design, said in a post on the University of Minnesota’s website.
There’s no definitive test for Alzheimer’s – it’s diagnosed based on symptoms – so the ability to see progression of the disease before symptoms appear could help experts test new preventive and treatment drugs.
The eye test will enter human trials this month, and it will be tested in both patients with and without Alzheimer’s disease.
As many as 5.1 million Americans could be suffering from Alzheimer’s disease, according to the Alzheimer’s Foundation of America. Warning signs include memory problems, word-finding difficulty, vision and spatial issues and off reasoning or judgment, according to the National Institute on Aging.
If you’re worried about Alzheimer’s disease, your best shot at prevention could be maintaining cardiovascular health through exercise and diet and staying on top of conditions such as diabetes and high blood pressure. That’s...
Alzheimer’s is one of the most common neurodegenerative diseases affecting millions today. Usually targeting people aged 60 and above, it works by slowly killing the neurons in various parts of our brain, making the person suffering from...
In recent years, one promising Alzheimer’s drug after another has failed to produce results in clinical trials. At the same time, the growing number of older adults with cognitive problems is reaching a crisis point. In...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.